Pfizer, BioNTech to expand vaccine Phase 3 trial
US-based pharmaceutical major Pfizer and German biotech firm BioNTech have announced to expand the enrollment of their Phase 3 Covid-19 vaccine trial to up to approximately 44,000 participants, up from an initial recruitment goal of 30,000 individuals.
from Times of India https://ift.tt/3bQdwAU
https://ift.tt/eA8V8J September 13, 2020 at 11:42AM
from Times of India https://ift.tt/3bQdwAU
https://ift.tt/eA8V8J September 13, 2020 at 11:42AM
Comments
Post a Comment